CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.

Raphael Bernard-Valnet Xavier MoissetNicolas MaubeugeMathilde LefebvreJean-Christophe OualletMathilde RoumierChristine Lebrun-Frénay Jonathan CironDamien BiottiPierre ClavelouBertrand GodeauRenaud A Du PasquierGuillaume Martin-Blondel

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

This study provides Class IV evidence showing that adding maraviroc to the management of iatrogenic iPML/PML-IRIS does not improve the outcome.

Keyphrases